The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice

The International Gynecologic Oncology Consensus Conference, titled Marrying Evidence to Practice, is a pivotal event taking place at the Hyatt Regency Boston. This conference is designed to convene international key opinion leaders in the field of gynecologic oncology to address critical issues of clinical equipoise in managing and surveilling ovarian, uterine, and cervical cancers. Aimed at synthesizing contemporary evidence that informs clinical practices, the conference seeks to develop consensus on decisions that have a direct impact on patient care.At the conference, voting panelists will engage in a thorough review of consensus statements, which will be followed by targeted lectures that provide the supporting evidence for those statements. Participants, including panelists and audience members, will be encouraged to discuss each statement before a second vote is conducted to solidify consensus. A consensus document will be crafted for publication, authored by the chairs, steering committee, and voting panelists. The significance of this conference lies in its ability to guide practicing gynecologic cancer providers in decision-making, particularly in areas where clinical scenarios leave patients with multiple management options. Notable speakers and panelists include experts from renowned institutions such as Binay Shah, MD, MHA from Tufts Medical Center, Linda R. Duska, M.D., MPH from UVA Health Sciences Center, and Deborah K. Armstrong, MD from Johns Hopkins Medicine, among others. Participants will leave the conference equipped to integrate contemporary data into clinical management, apply current evidence to enhance their understanding of treatment paradigms, and identify key questions where consensus has been developed by leading experts. They will also be trained to critically evaluate areas of clinical equipoise and apply consensus-based recommendations tailored to individual patient care. This conference represents 17 years of advocacy, education, and innovation dedicated to improving cancer care, facilitated by Binaytara, a 501(c)(3) not-for-profit organization.